These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 3707011)
1. [Effects on the systemic and coronary circulation of a new IC-group anti-arrhythmia agent: propafenone. Hemodynamic study of 10 patients in the basal state and under auricular electric stimulation, before and after the intravenous injection of propafenone]. Fernandez F; Boyibanga J; Vrancea F; Maarek-Charbit M; Genet P; Gay J Ann Cardiol Angeiol (Paris); 1986 Feb; 35(2):119-22. PubMed ID: 3707011 [No Abstract] [Full Text] [Related]
2. [Experimental characterization of propafenone. Hemodynamic effects]. Botti G; Aurier E; Finardi A G Ital Cardiol; 1984 May; 14(5):373-6. PubMed ID: 6468819 [TBL] [Abstract][Full Text] [Related]
3. [Effects of propafenone on coronary and systemic hemodynamics]. Terrosu P; Ibba GV; Franceschino V; Contini GM; Delpini A G Ital Cardiol; 1986 Apr; 16(4):321-7. PubMed ID: 3743935 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the hemodynamic effects and anti-arrhythmic activity of propafenone: from new frontiers to clinical verification]. Lotto A; Finzi A G Ital Cardiol; 1986 Apr; 16(4):333-5. PubMed ID: 3743936 [No Abstract] [Full Text] [Related]
5. [Hemodynamic action of propafenon in patients with atherosclerotic coronary disease]. Lamounier EN; Martinez Filho EE; Herrmann JL; Guimarães RD; Portugal OP; Barcellini A Arq Bras Cardiol; 1979 Jul; 33(1):73-6. PubMed ID: 526178 [No Abstract] [Full Text] [Related]
6. Assessment of the antiarrhythmic profile of the new class I agent diprafenone. Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340 [TBL] [Abstract][Full Text] [Related]
7. [Profile of a new anti-arrhythmic agent: propafenon. I. Electrophysiologic characterization]. Disertori M; Vergara G; Dal Forno P; Inama G; Furlanello F Boll Soc Ital Cardiol; 1981; 26(1):75-85. PubMed ID: 7340862 [No Abstract] [Full Text] [Related]
8. [Effects of diltiazem on cardiac and coronary circulation, at rest and during rapid auricular electric stimulation]. Fernandez F; Belfante M; Juillard A; Batalla N; Baclet M; Apoil E; Gay J; Gerbaux A Arch Mal Coeur Vaiss; 1983 Jan; 76(1):61-70. PubMed ID: 6405716 [TBL] [Abstract][Full Text] [Related]
9. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations. Naccarella FF; Agarwal JB; Weintraub WS; Bracchetti D; Helfant RH G Ital Cardiol; 1984 Oct; 14(10):825-9. PubMed ID: 6519392 [TBL] [Abstract][Full Text] [Related]
10. [Study of hemodynamic and coronary effects induced by intravenous injection of disopyramide administered to coronary failure and congestive heart failure patients (author's transl)]. Pornin M; Roland E; Lardoux H; Sellier P; Morin D; Ourbak P; Maurice P Therapie; 1981; 36(2):179-86. PubMed ID: 7292392 [No Abstract] [Full Text] [Related]
11. [Effect of propafenone on left ventricular function in patients with myocardial infarct]. Arrigo F; Bonanno N; Baldari S; Giannetto M; Luzza F Cardiologia; 1985 May; 30(5):379-85. PubMed ID: 3833350 [No Abstract] [Full Text] [Related]
13. [Anti-arrhythmic effects of propafenone in coronary patients with ventricular arrhythmias]. Fiol M; Palma JL; Bayés de Luna A; Aza V; Sadurní J Rev Esp Cardiol; 1984; 37(3):196-200. PubMed ID: 6505351 [No Abstract] [Full Text] [Related]
14. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction. Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385 [TBL] [Abstract][Full Text] [Related]
15. Propafenone for the treatment of severe ventricular arrhythmias. Rabkin SW; Rotem CE; Boroomand-Rashti K; Bar-Shlomo B Can Med Assoc J; 1984 Sep; 131(6):601-3. PubMed ID: 6478345 [TBL] [Abstract][Full Text] [Related]
16. [Effect of propafenone on the pharmacokinetics of digoxin administered orally: a study in healthy volunteers]. Cardaioli P; Compostella L; De Domenico R; Papalia D; Zeppellini R; Libardoni M; Pulido E; Cucchini F G Ital Cardiol; 1986 Mar; 16(3):237-40. PubMed ID: 3732716 [TBL] [Abstract][Full Text] [Related]
17. [Hemodynamic and coronary effects of molsidomine in patients with stable coronary insufficiency in the basal state, during an atrial stimulation test and a cold test]. Gourgon R; Neukirch F; Zygelman M; Michel PL; Mérillon JP; Pansard Y; Squara P; Laurent S; Dahan M; Juliard JM Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):529-34. PubMed ID: 6689395 [TBL] [Abstract][Full Text] [Related]
18. [Observations on the anti-arrhythmic effects of propafenone]. Ku FS Zhonghua Nei Ke Za Zhi; 1982 Nov; 21(11):658-61. PubMed ID: 7166067 [No Abstract] [Full Text] [Related]
19. Electrophysiological effects of propafenone studied with programmed electrical stimulation of the heart in patients with recurrent paroxysmal supraventricular tachycardia. Waleffe A; Mary-Rabine L; de Rijbel R; Soyeur D; Legrand V; Kulbertus HE Eur Heart J; 1981 Aug; 2(4):345-52. PubMed ID: 7297575 [No Abstract] [Full Text] [Related]
20. [Propafenone--a new generation anti-arrhythmia agent]. Fischer M Med Klin; 1980 Jan; 75(1):39-41. PubMed ID: 6988688 [No Abstract] [Full Text] [Related] [Next] [New Search]